Update: Interim guidance for health care professionals evaluating and caring for patients with suspected E-cigarette, or vaping, product use–associated lung injury and for reducing the risk for rehospitalization and death following hospital discharge — United States, December 2019

Lung Injury Response Clinical Task Force; Lung Injury Response Clinical Working Group

Research output: Contribution to journalArticle

Abstract

What is already known on this topic? In a recent examination of rehospitalization and death among previously hospitalized patients with e-cigarette or vaping, product use–associated lung injury (EVALI), at least one quarter of rehospitalizations and deaths occurred within 2 days of discharge; comorbidities were common among patients who were rehospitalized or who died after discharge. What is added by this report? Updated guidance recommends posthospitalization outpatient follow-up, optimally within 48 hours of discharge, and emphasizes the importance of preparation for hospital discharge and postdischarge care coordination to reduce risk of rehospitalization and death among hospitalized EVALI patients. What are the implications for public health practice? Incorporating this updated guidance into the management of hospitalized EVALI patients might reduce EVALI-associated morbidity and mortality.

Original languageEnglish (US)
Pages (from-to)1189-1194
Number of pages6
JournalMorbidity and Mortality Weekly Report
Volume68
Issue number51-52
StatePublished - Jan 3 2020

ASJC Scopus subject areas

  • Epidemiology
  • Health(social science)
  • Health, Toxicology and Mutagenesis
  • Health Information Management

Fingerprint Dive into the research topics of 'Update: Interim guidance for health care professionals evaluating and caring for patients with suspected E-cigarette, or vaping, product use–associated lung injury and for reducing the risk for rehospitalization and death following hospital discharge — United States, December 2019'. Together they form a unique fingerprint.

  • Cite this